Braun Stacey Associates Inc. Trims Position in Itron, Inc. $ITRI

Braun Stacey Associates Inc. decreased its position in shares of Itron, Inc. (NASDAQ:ITRI) by 5.2% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 205,919 shares of the scientific and technical instruments company’s stock after selling 11,185 shares during the quarter. Braun Stacey Associates Inc. owned approximately 0.45% of Itron worth $25,649,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of the business. Twin Peaks Wealth Advisors LLC purchased a new position in shares of Itron in the second quarter valued at about $30,000. Bessemer Group Inc. raised its stake in Itron by 125.7% during the 2nd quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock valued at $34,000 after purchasing an additional 142 shares during the period. Salomon & Ludwin LLC purchased a new position in Itron in the 3rd quarter worth approximately $42,000. Northwestern Mutual Wealth Management Co. boosted its stake in Itron by 343.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after purchasing an additional 268 shares during the period. Finally, EverSource Wealth Advisors LLC boosted its stake in Itron by 25.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after purchasing an additional 81 shares during the period. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on ITRI. Stephens upgraded shares of Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price objective on the stock in a research report on Monday, November 3rd. Weiss Ratings reiterated a “buy (b-)” rating on shares of Itron in a report on Monday. Argus reissued a “hold” rating on shares of Itron in a report on Tuesday, November 4th. Robert W. Baird restated a “neutral” rating and set a $118.00 price objective (down previously from $137.00) on shares of Itron in a research report on Friday, October 31st. Finally, Zacks Research downgraded Itron from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 12th. Nine research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $139.00.

Itron Stock Performance

Shares of NASDAQ:ITRI opened at $92.86 on Friday. The firm has a fifty day simple moving average of $101.34 and a two-hundred day simple moving average of $118.58. Itron, Inc. has a 52 week low of $90.11 and a 52 week high of $142.00. The company has a quick ratio of 1.91, a current ratio of 2.17 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $4.25 billion, a P/E ratio of 16.70, a PEG ratio of 0.45 and a beta of 1.49.

Itron (NASDAQ:ITRI) last announced its earnings results on Thursday, October 30th. The scientific and technical instruments company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.06. The firm had revenue of $581.63 million for the quarter, compared to analysts’ expectations of $578.49 million. Itron had a net margin of 10.69% and a return on equity of 17.82%. The business’s revenue was down 5.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.84 EPS. Itron has set its FY 2025 guidance at 6.840-6.940 EPS and its Q4 2025 guidance at 2.150-2.250 EPS. On average, analysts expect that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, SVP John F. Marcolini sold 553 shares of Itron stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $53,370.03. Following the completion of the transaction, the senior vice president owned 13,843 shares in the company, valued at approximately $1,335,987.93. The trade was a 3.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Donald L. Reeves III sold 536 shares of the stock in a transaction on Monday, November 24th. The shares were sold at an average price of $96.51, for a total value of $51,729.36. Following the sale, the senior vice president owned 19,068 shares in the company, valued at $1,840,252.68. The trade was a 2.73% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 2,971 shares of company stock worth $286,731. 1.45% of the stock is currently owned by company insiders.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.